FIGURE

Figure 3

ID

ZDB-FIG-200725-22

Publication

Toms et al., 2020 - Clinical and preclinical therapeutic outcome metrics for USH2A-related disease

Other Figures

All Figure Page

Back to All Figure Page

Figure 3

Inter-relatedness of progression between metrics. While there is a strong correlation between the rate of change observed in the first and second observation periods for both EZ length constriction (A) and hyperautofluorescence (hyperAF) ring constriction (B), neither correlation line describes the data well (r² = 0.207 and 0.227 respectively). The ratio of EZ length and hyperAF ring constriction accounts for a much greater share of the variability (C, r² = 0.4355).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Hum. Mol. Genet.